Frontlight ResearchEarly access
Neuroblastoma trials in Russia
2 of 3 trials · From ClinicalTrials.gov, checked 17 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleChemoimmunotherapy Combined With Autologous NK Cell Therapy for Pediatric Patients With Refractory and Relapsed High-Risk Neuroblastoma and Ganglioneuroblastoma
- Where
- Moscow
- Age
- 18 months to 18 years
- People
- 5
- Run by
- Federal Research Institute of Pediatric Hematology, Oncology and Immunology
See details and how to joinNCT07375563 - Phase 3Taking peopleInduction Chemoimmunotherapy for Patients With High-risk Neuroblastoma
- Where
- Moscow
- Age
- 18 months to 18 years
- People
- 15
- Run by
- Federal Research Institute of Pediatric Hematology, Oncology and Immunology
See details and how to joinNCT06071897